Spartan Fund Management’s American Oncology Network, Inc. Warrant AONCW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-47,765
Closed -$9.51K 271
2023
Q3
$9.51K Sell
47,765
-56,305
-54% -$13K 0.01% 166
2023
Q2
$14.9K Buy
104,070
+56,305
+118% +$4.62K ﹤0.01% 232
2023
Q1
$3.42K Hold
47,765
﹤0.01% 301
2022
Q4
$3K Buy
+47,765
New +$3.91K ﹤0.01% 347

Other funds holding AONCW

Spartan Fund Management's AONCW Position: Q4 2023 in Review

Spartan Fund Management sold out of American Oncology Network, Inc. Warrant (AONCW) in Q4 2023, closing a stake of 47,765 shares — an estimated $9.51K sold.

Spartan Fund Management first reported a position in AONCW in Q4 2022 and held it in 4 quarters. The position peaked at $14.9K in Q2 2023. 32 funds tracked by Wall St. Rank hold AONCW as of Q4 2023.

  • Spartan Fund Management reported no remaining American Oncology Network, Inc. Warrant position as of Q4 2023 after selling out during the quarter.
  • Spartan Fund Management sold 47,765 American Oncology Network, Inc. Warrant shares in Q4 2023, an estimated $9.51K.
  • Spartan Fund Management first reported a position in American Oncology Network, Inc. Warrant in Q4 2022 and held it in 4 quarters.
  • Spartan Fund Management's American Oncology Network, Inc. Warrant position peaked at $14.9K in Q2 2023.
  • 32 funds tracked by Wall St. Rank held American Oncology Network, Inc. Warrant as of Q4 2023.

Based on Spartan Fund Management's 13F filing for Q4 2023, filed 7 Feb 2024.